Items where Author is "Weisel, Katja"

Article

Merz, Maximilian and Gagelmann, Nico and Smaili, Samih and Flossdorf, Sarah and Sauer, Sandra and Scheid, Christof and von Tresckow, Bastian and Wulf, Gerald and Weisel, Katja and Blau, Igor Wolfgang and Engelhardt, Monika and Wasch, Ralph and Schub, Natalie and Teipel, Raphael and Hecker, Judith and Waldschmidt, Johannes and Besemer, Britta and Baermann, Ben-Niklas and Call, Simon and Hansmann, Leo and Ayuk, Francis Ayuketang and Raab, Marc S. and Einsele, Hermann and Platzbecker, Uwe and Kroger, Nicolaus (2025) Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST. BLOOD, 146 (14). pp. 1677-1686. ISSN 0006-4971, 1528-0020

Weidmann, Eckhart and Hess, Georg and Krause, Stefan W. and Subklewe, Marion and Kruse, Judith and Soekler, Martin and Weisel, Katja and Kim, Soo-Zin and Dreyling, Martin H. and Jager, Elke (2006) A phase II immunochemotherapy study with alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD) in peripheral T-cell lymphomas. BLOOD, 108 (11): 2721. 769A. ISSN 0006-4971

Conference or Workshop Item

Einsele, Hermann and Liebisch, Peter and Langer, Christian and Kropff, Martin and Wandt, Hannes and Jung, Wolfram and Kroeger, Nikolaus and Engelhardt, Monika and Ostermann, Helmut and Muegge, Lars-Olof and Wolf, Hans-Heinrich and Hart, Christina and Metzner, Bernd and Kaufmann, Martin and Gramatzki, Martin and Hertenstein, Bernd and Fischer, Thomas and Weisel, Katja and Doelken, Gottfried and Brugger, Wolfram and Gollasch, Hella and Maschmeyer, Georg and Pfreundschuh, Michael and Schmitz, Norbert and Sezer, Orhan and Heidemann, Else and Jaeger, Elke and Kahl, Christoph and Kiani, Alexander and Dechow, Tobias and Roesler, Wolf and Simon, Jan Philipp and Duerk, Heinz and Pflueger, Karl Heinz and Bentz, Martin and Hess, Georg and Mergenthaler, Hans-Guenther and Straka, Christian and Hempel, Dirk and Salwender, Hans-Juergen and Fingerle-Rowson, Guenter and Knop, Stefan (2009) Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial). In: 51st Annual Meeting of the American Society of Hematology, December 05-08, 2009, New Orleans, LA.